Today: 13 May 2026
GE Aerospace Shareholder Fight Intensifies as ADL, JLens Urge Rejection of Proposal 7
30 March 2026
1 min read

GE Aerospace Shareholder Fight Intensifies as ADL, JLens Urge Rejection of Proposal 7

NEW YORK, March 30, 2026, 12:04 EDT

ADL and JLens urged GE Aerospace shareholders on Monday to vote down Proposal 7, which heads to the ballot at the jet-engine giant’s May 5 annual meeting. The measure calls for an independent probe into how GE assesses human-rights risks tied to its defense products’ end users. GE’s board is already recommending a no vote.

GE is ramping up defense production as competition intensifies. The company revealed earlier this month it will inject an additional $1 billion into its U.S. manufacturing operations for 2026, with over $275 million designated specifically for defense engine plants. CEO Larry Culp said U.S. aerospace strength hinges on “sustained investment” in talent, infrastructure, and technology. GE Aerospace

Presbyterian Foundation is behind Proposal 7, which asks GE to bring in an outside firm to audit its due-diligence practices. The assessment would focus on how GE assesses the risk that its defense products could be tied to human-rights abuses or breaches of international laws of war in areas marked by conflict or classified as high-risk.

GE’s proxy says generating the report isn’t worth the cost or time, claiming shareholders wouldn’t get much out of it. The board points to existing U.S. export controls and trade rules covering defense sales, and notes that GE has trade-compliance, sanctions, and human-rights programs it believes are comparable to peers.

Jonathan Greenblatt, who heads the ADL, called Proposal 7 “fundamentally discriminatory.” Over at JLens, managing director Ari Hoffnung said the proposal was forcing “a political agenda into the boardroom.” The two groups insist foreign military sales are governed by U.S. export controls and federal rules, not solely GE. ADL

The supporting statement calls for more transparency, arguing investors should get a clearer picture. It points to GE’s track record of supplying products to armed forces accused of wrongdoing—highlighting equipment delivered to the Israeli Defense Forces specifically. The statement says beefed-up disclosure would help GE assess and address risk, and bring its approach in line with industry peers.

This governance decision stands out. GE’s Defense & Propulsion Technologies arm pulled in $10.6 billion in revenue for 2025, and shareholders saw an 86% total return last year. Shares dropped $6.32 by midday Monday, trading at $276.49.

The real issue now: not only whether Proposal 7 fails, but how much traction it gets. Should backing come in above GE’s own estimates, the company could be staring down more heat during next year’s proxy contests. The terrain has changed, too, since the SEC in November decided to stop providing detailed feedback on most no-action requests to block shareholder proposals.

GE’s annual meeting goes virtual this year, set for May 5 at 10:00 a.m. Eastern. Shareholders are expected to vote on Proposal 7, choose directors, weigh in on executive pay, and review additional matters laid out in the 2026 proxy.

Stock Market Today

  • 10x Genomics Shares Drop 5.3% After Q1 Revenue Miss Raises Growth Fears
    May 13, 2026, 12:21 AM EDT. 10x Genomics (TXG) shares fell 5.3% following quarterly results that beat forecasts but showed a 2.6% revenue decline year-over-year to $150.8 million. Despite narrowing losses and reconfirming full-year guidance, investors reacted to concerns about future growth prospects. The stock closed at $21.61, down 3.6% from the previous close. Volatility remains high with 54 price swings over 5% in the past year. Investor caution appears linked to weaker growth signals in the life sciences sector, highlighted by peer Thermo Fisher's slower organic revenue gain. Although 10x Genomics is up 29.9% year-to-date, shares remain 17.2% below their 52-week peak. The market seems to weigh near-term sales softness against long-term potential cautiously.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.05.2026

13 May 2026
LIVEMarkets rolling coverageStarted: May 13, 2026, 12:00 AM EDTUpdated: May 13, 2026, 12:36 AM EDT 10x Genomics Shares Drop 5.3% After Q1 Revenue Miss Raises Growth Fears May 13, 2026, 12:21 AM EDT. 10x Genomics (TXG) shares fell 5.3% following quarterly results that beat forecasts but showed a 2.6% revenue decline year-over-year to $150.8 million. Despite narrowing losses and reconfirming full-year guidance, investors reacted to concerns about future growth prospects. The stock closed at $21.61, down 3.6% from the previous close. Volatility remains high with 54 price swings over 5% in the past year. Investor caution appears linked to weaker
US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

13 May 2026
Tech stocks led declines Tuesday after April CPI data showed consumer prices rose 0.6% for the month and 3.8% year-over-year, pushing Treasury yields higher and weighing on rate-cut hopes. Brent crude settled above $107, fueling inflation concerns. The S&P 500 slipped 11.88 points to 7,400.96, while the Nasdaq lost 185.92 to 26,088.20. Chip stocks fell sharply, with Qualcomm down 11% and Intel off 6.8%.
Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

13 May 2026
Karman Holdings shares closed up 6.2% at $62.48 on May 12, then fell 11% after hours following first-quarter results and a raised 2026 outlook. Q1 revenue jumped 51% to $151.2 million, net income reached $7.8 million, and backlog hit $1.0 billion. Adjusted EPS matched the $0.11 estimate. The company announced over $1 billion in new contingent demand commitments.
AST SpaceMobile Sets April 10 BlueBird 7 Target as Rocket Lab Notches ESA Launch After SpaceX IPO Buzz
Previous Story

AST SpaceMobile Sets April 10 BlueBird 7 Target as Rocket Lab Notches ESA Launch After SpaceX IPO Buzz

Dow Jones Index Today: Dow Jumps 300 Points as Wall Street Tries to Shake Off Correction
Next Story

Dow Jones Index Today: Dow Jumps 300 Points as Wall Street Tries to Shake Off Correction

Go toTop